Free Trial
TSE:BLU

BELLUS Health (BLU) Stock Price, News & Analysis

BELLUS Health logo

About BELLUS Health Stock (TSE:BLU)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
28,666 shs
Average Volume
59,471 shs
Market Capitalization
C$2.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BLU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

BLU Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
See More Headlines

BLU Stock Analysis - Frequently Asked Questions

Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that BELLUS Health investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Advanced Micro Devices (AMD), Algonquin Power & Utilities (AQN), BCE (BCE), Canadian Natural Resources (CNQ) and Nutrien (NTR).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:BLU
CIK
N/A
Fax
N/A
Employees
74
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.96)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$86.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-26.76%
Return on Assets
-16.70%

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
33.42
Quick Ratio
16.40

Sales & Book Value

Annual Sales
C$16 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
4.67
Book Value
C$2.91 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
126,810,000
Free Float
N/A
Market Cap
C$2.47 billion
Optionable
Not Optionable
Beta
-0.28
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (TSE:BLU) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners